Systemic Immune-Inflammation Index is a Prognostic Predictor for Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis.

Chan-Juan WeiJuan-Juan XueXiao ZhouXiao-Shuang XiaXin Li

Published in: The neurologist (2023)

Increased baseline SII was associated with END and 3-month poor outcomes, and may act as a potential prognostic predictor for acute ischemic stroke patients treated with intravenous thrombolysis.

Keyphrases

acute ischemic stroke
high dose
oxidative stress
metabolic syndrome
adipose tissue
newly diagnosed
insulin resistance
weight loss